These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24805060)

  • 1. Tuning HERG out: antitarget QSAR models for drug development.
    Braga RC; Alves VM; Silva MF; Muratov E; Fourches D; Tropsha A; Andrade CH
    Curr Top Med Chem; 2014; 14(11):1399-415. PubMed ID: 24805060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pred-hERG: A Novel web-Accessible Computational Tool for Predicting Cardiac Toxicity.
    Braga RC; Alves VM; Silva MF; Muratov E; Fourches D; Lião LM; Tropsha A; Andrade CH
    Mol Inform; 2015 Oct; 34(10):698-701. PubMed ID: 27490970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing hERG Risk Assessment with Interpretable Classificatory and Regression Models.
    Sanches IH; Braga RC; Alves VM; Andrade CH
    Chem Res Toxicol; 2024 Jun; 37(6):910-922. PubMed ID: 38781421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hERG classification model based on a combination of support vector machine method and GRIND descriptors.
    Li Q; Jørgensen FS; Oprea T; Brunak S; Taboureau O
    Mol Pharm; 2008; 5(1):117-27. PubMed ID: 18197627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of an integrated database for hERG blocking small molecules.
    Sato T; Yuki H; Ogura K; Honma T
    PLoS One; 2018; 13(7):e0199348. PubMed ID: 29979714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
    Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers.
    Thai KM; Ecker GF
    Mol Divers; 2009 Aug; 13(3):321-36. PubMed ID: 19219559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of the hERG K+ Channel Blockage Using Online Chemical Database and Modeling Environment (OCHEM).
    Li X; Zhang Y; Li H; Zhao Y
    Mol Inform; 2017 Dec; 36(12):. PubMed ID: 28857516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Study on the hERG Blocker Prediction Using Chemical Fingerprint Analysis.
    Choi KE; Balupuri A; Kang NS
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32512802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Catch-22 of Predicting hERG Blockade Using Publicly Accessible Bioactivity Data.
    Siramshetty VB; Chen Q; Devarakonda P; Preissner R
    J Chem Inf Model; 2018 Jun; 58(6):1224-1233. PubMed ID: 29772901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A binary QSAR model for classification of hERG potassium channel blockers.
    Thai KM; Ecker GF
    Bioorg Med Chem; 2008 Apr; 16(7):4107-19. PubMed ID: 18243713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-Access Activity Prediction Tools for Natural Products. Case Study: hERG Blockers.
    Mayr F; Vieider C; Temml V; Stuppner H; Schuster D
    Prog Chem Org Nat Prod; 2019; 110():177-238. PubMed ID: 31621014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico binary classification QSAR models based on 4D-fingerprints and MOE descriptors for prediction of hERG blockage.
    Su BH; Shen MY; Esposito EX; Hopfinger AJ; Tseng YJ
    J Chem Inf Model; 2010 Jul; 50(7):1304-18. PubMed ID: 20565102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine-learning technique, QSAR and molecular dynamics for hERG-drug interactions.
    Das NR; Sharma T; Toropov AA; Toropova AP; Tripathi MK; Achary PGR
    J Biomol Struct Dyn; 2023; 41(23):13766-13791. PubMed ID: 37021352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A k-nearest neighbor classification of hERG K(+) channel blockers.
    Chavan S; Abdelaziz A; Wiklander JG; Nicholls IA
    J Comput Aided Mol Des; 2016 Mar; 30(3):229-36. PubMed ID: 26860111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico classification of HERG channel blockers: a knowledge-based strategy.
    Dubus E; Ijjaali I; Petitet F; Michel A
    ChemMedChem; 2006 Jun; 1(6):622-30. PubMed ID: 16892402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indexing molecules for their hERG liability.
    Rayan A; Falah M; Raiyn J; Da'adoosh B; Kadan S; Zaid H; Goldblum A
    Eur J Med Chem; 2013 Jul; 65():304-14. PubMed ID: 23727540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in computational prediction of HERG blockage.
    Wang S; Li Y; Xu L; Li D; Hou T
    Curr Top Med Chem; 2013; 13(11):1317-26. PubMed ID: 23675938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.
    Wang S; Li Y; Wang J; Chen L; Zhang L; Yu H; Hou T
    Mol Pharm; 2012 Apr; 9(4):996-1010. PubMed ID: 22380484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico predictions of hERG channel blockers in drug discovery: from ligand-based and target-based approaches to systems chemical biology.
    Taboureau O; Jørgensen FS
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):375-87. PubMed ID: 21470179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.